MOLSON COORS BEV B DL0,01/ US60871R2094 /
2024-05-17 9:54:18 PM | Chg. -0.900 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
51.940EUR | -1.70% | 53 Turnover: 2,760.040 |
51.840Bid Size: 287 | 52.040Ask Size: 287 | 10.49 bill.EUR | - | - |
GlobeNewswire
12:11 AM
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
12:00 AM
ADSK Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Act...
GlobeNewswire
05-17
NCLA Tells Department of Education Its Newest Student Loan Debt Cancellation Plan Is Unlawful
GlobeNewswire
05-17
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of...
GlobeNewswire
05-17
Lincoln National Corporation investors: Please contact the Portnoy Law Firm to recover your losses; ...
GlobeNewswire
05-17
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic ...
GlobeNewswire
05-17
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
05-17
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
05-17
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
05-17
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
05-17
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...